Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cubist evaluating new class of antibacterial agents

Oct. 11, 1996

New family of marine natural products discovered

Oct. 11, 1996

Procter & Gamble focuses on multifunctional antibacterial agents

Oct. 11, 1996

MC-02331, a new cephalosporin with excellent activity against Gram-positive bacteria

Oct. 11, 1996

Metallo-beta-lactamase inhibitors from SKB

Oct. 11, 1996

Penam sulfones with beta-lactamase-inhibitory activity

Oct. 11, 1996

Prodesfarma presents cardiovascular candidate

Oct. 4, 1996

New agent for CMV infection from Glaxo Wellcome

Oct. 4, 1996

Pharmacia & Upjohn details the activity of new HIV protease inhibitor

Oct. 4, 1996

Development of ViroPharma's lead antiviral drug progresses

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...